BIO-TECHNE Corp Available-for-sale Securities, Current
BIO-TECHNE Corp (TECH) had Available-for-sale Securities, Current of $32.46 million as of 2021-06-30, per its 10-K filed 2021-08-25.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesCurrent · last filed 2021-08-25
- 2021-06-30: Available-for-sale Securities, Current $32.46M.
- 2021-03-31: Available-for-sale Securities, Current $90.11M.
- 2020-12-31: Available-for-sale Securities, Current $117.43M.
- 2020-09-30: Available-for-sale Securities, Current $117.99M.
| Period end | Available-for-sale Securities, Current |
|---|---|
| 2021-06-30 | $32.46M 10-K · filed 2021-08-25 |
| 2021-03-31 | $90.11M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $117.43M 10-Q · filed 2021-02-08 |
| 2020-09-30 | $117.99M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $124.27M 10-K · filed 2021-08-25 |
| 2020-03-31 | $104.87M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $133.66M 10-Q · filed 2020-02-06 |
| 2019-09-30 | $58.52M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $65.15M 10-K · filed 2020-08-26 |
| 2019-03-31 | $83.23M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $70.65M 10-Q · filed 2019-02-07 |
| 2018-09-30 | $69.05M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $59.76M 10-K/A · filed 2019-11-06 |
| 2018-03-31 | $89.83M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $40.93M 10-Q · filed 2018-02-08 |
| 2017-09-30 | $50.26M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $66.10M 10-K · filed 2018-08-27 |
| 2017-03-31 | $53.78M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $56.56M 10-Q · filed 2017-02-09 |
| 2016-09-30 | $52.38M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $31.60M 10-K · filed 2017-09-07 |
| 2016-03-31 | $18.87M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $51.47M 10-Q · filed 2016-02-09 |
| 2015-09-30 | $38.42M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $56.39M 10-K · filed 2016-08-29 |
| 2015-03-31 | $53.50M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $46.97M 10-Q · filed 2015-02-09 |
| 2014-09-30 | $32.57M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $44.79M 10-K · filed 2015-08-31 |
| 2014-03-31 | $96.53M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $88.45M 10-Q · filed 2014-02-04 |
| 2013-09-30 | $100.84M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $169.15M 10-K · filed 2014-08-29 |
| 2013-03-31 | $162.16M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $142.81M 10-Q · filed 2013-02-11 |
| 2012-09-30 | $142.26M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $152.31M 10-K · filed 2013-08-29 |
| 2012-03-31 | $124.33M 10-Q · filed 2012-05-10 |
| 2011-06-30 | $63.20M 10-K · filed 2012-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |